Outbreak Column 15: Carbapenemase-producing Enterobacteriaceae.
作者信息
Curran Evonne T, Otter Jonathan A
机构信息
NHS National Services Scotland, Health Protection Scotland, Glasgow.
Centre for Clinical Infection and Diagnostics Research, Guy's and St. Thomas NHS Foundation Trust / King's College London, and Bioquell.
出版信息
J Infect Prev. 2014 Sep;15(5):193-198. doi: 10.1177/1757177414546707.
Abstract
摘要
相似文献
1
Outbreak Column 15: Carbapenemase-producing Enterobacteriaceae.爆发专栏15：产碳青霉烯酶肠杆菌科细菌
J Infect Prev. 2014 Sep;15(5):193-198. doi: 10.1177/1757177414546707.
2
[Investigation of carbapenemase genes and molecular epidemiology of Enterobacteriaceae strains isolated between 2010-2014 in a university hospitals].[2010 - 2014年间在某大学医院分离的肠杆菌科菌株的碳青霉烯酶基因及分子流行病学调查]
Mikrobiyol Bul. 2018 Jan;52(1):1-12. doi: 10.5578/mb.66156.
3
An Irish outbreak of New Delhi metallo-β-lactamase (NDM)-1 carbapenemase-producing Enterobacteriaceae: increasing but unrecognized prevalence.爱尔兰新德里金属β-内酰胺酶（NDM）-1产碳青霉烯酶肠杆菌科细菌的暴发：患病率不断上升但未被认识到。
J Hosp Infect. 2016 Dec;94(4):351-357. doi: 10.1016/j.jhin.2016.08.005. Epub 2016 Aug 19.
4
Molecular characteristics of carbapenemase-producing Enterobacteriaceae in China from 2008 to 2011: predominance of KPC-2 enzyme.2008 年至 2011 年中国产碳青霉烯酶肠杆菌科细菌的分子特征：以 KPC-2 酶为主导。
Diagn Microbiol Infect Dis. 2014 Jan;78(1):63-5. doi: 10.1016/j.diagmicrobio.2013.10.002. Epub 2013 Oct 14.
5
Combined use of the modified Hodge test and carbapenemase inhibition test for detection of carbapenemase-producing Enterobacteriaceae and metallo-β-lactamase-producing Pseudomonas spp.改良 Hodge 试验与碳青霉烯酶抑制试验联合用于检测产碳青霉烯酶肠杆菌科细菌和产金属β-内酰胺酶铜绿假单胞菌属细菌
Ann Lab Med. 2015 Mar;35(2):212-9. doi: 10.3343/alm.2015.35.2.212. Epub 2015 Feb 12.
6
The association between colonization with carbapenemase-producing enterobacteriaceae and overall ICU mortality: an observational cohort study.产碳青霉烯酶肠杆菌科细菌定植与重症监护病房总体死亡率之间的关联：一项观察性队列研究。
Crit Care Med. 2015 Jun;43(6):1170-7. doi: 10.1097/CCM.0000000000001028.
7
Detection of the novel IMP-38 among carbapenemase-producing Enterobacteriaceae in a university hospital, China.在中国一家大学医院产碳青霉烯酶肠杆菌科细菌中检测新型IMP-38
J Infect Dev Ctries. 2014 Aug 13;8(8):1044-8. doi: 10.3855/jidc.4179.
8
National survey of colistin resistance among carbapenemase-producing Enterobacteriaceae and outbreak caused by colistin-resistant OXA-48-producing Klebsiella pneumoniae, France, 2014.2014年法国产碳青霉烯酶肠杆菌科细菌对黏菌素耐药情况的全国性调查以及由产OXA-48型黏菌素耐药肺炎克雷伯菌引起的暴发
Euro Surveill. 2016 Sep 15;21(37). doi: 10.2807/1560-7917.ES.2016.21.37.30339.
9
Antecedent Carbapenem Exposure as a Risk Factor for Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae and Carbapenemase-Producing Enterobacteriaceae.碳青霉烯类药物暴露前史是产非碳青霉烯酶类碳青霉烯耐药肠杆菌科和产碳青霉烯酶肠杆菌科的危险因素。
Antimicrob Agents Chemother. 2019 Sep 23;63(10). doi: 10.1128/AAC.00845-19. Print 2019 Oct.
10
Phenotypic determination of carbapenemase producing enterobacteriaceae isolates from clinical specimens at a tertiary hospital in Lagos, Nigeria.尼日利亚拉各斯一家三级医院临床标本中产碳青霉烯酶肠杆菌科分离株的表型鉴定
Niger Postgrad Med J. 2015 Oct-Dec;22(4):223-7. doi: 10.4103/1117-1936.173973.
引用本文的文献
1
IS-Mediated Transfer of as the Main Route of Resistance Transmission During a Polyclonal, Multispecies Outbreak in a German Hospital.在德国一家医院的多克隆、多物种爆发期间，IS介导的[具体物质]转移作为耐药性传播的主要途径。 （注：原文中“of”后面似乎缺失关键信息）
Front Microbiol. 2019 Dec 17;10:2817. doi: 10.3389/fmicb.2019.02817. eCollection 2019.
本文引用的文献
1
Outbreak Column 13: Nosocomial outbreaks (part 2 - guidelines).突发情况专栏13：医院内感染暴发（第2部分 - 指南）
J Infect Prev. 2014 Mar;15(2):69-73. doi: 10.1177/1757177414520815. Epub 2014 Feb 28.
2
Outbreak Column 12: Nosocomial outbreaks (part 1).突发情况专栏12：医院感染暴发（第1部分）。
J Infect Prev. 2014 Jan;15(1):36-40. doi: 10.1177/1757177413513817. Epub 2013 Nov 28.
3
Deaths attributable to carbapenem-resistant Enterobacteriaceae infections.由耐碳青霉烯类肠杆菌科细菌感染导致的死亡病例。
Emerg Infect Dis. 2014 Jul;20(7):1170-5. doi: 10.3201/eid2007.121004.
4
Long-term carriage of Klebsiella pneumoniae carbapenemase-2-producing K pneumoniae after a large single-center outbreak in Germany.德国一个大型单中心暴发后产肺炎克雷伯菌碳青霉烯酶-2肺炎克雷伯菌的长期携带情况
Am J Infect Control. 2014 Apr;42(4):376-80. doi: 10.1016/j.ajic.2013.12.001.
5
Risk factors for colonization due to carbapenem-resistant Enterobacteriaceae among patients exposed to long-term acute care and acute care facilities.长期急性护理和急性护理机构中患者感染耐碳青霉烯类肠杆菌科细菌的危险因素。
Infect Control Hosp Epidemiol. 2014 Apr;35(4):398-405. doi: 10.1086/675614.
6
Duration of colonization with antimicrobial-resistant bacteria after ICU discharge.重症监护病房出院后抗菌药物耐药菌的定植持续时间。
Intensive Care Med. 2014 Apr;40(4):564-71. doi: 10.1007/s00134-014-3225-8. Epub 2014 Feb 13.
7
8
epic3: national evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England.epic3：英格兰国民保健署医院内医源性感染预防的国家循证指南。
J Hosp Infect. 2014 Jan;86 Suppl 1:S1-70. doi: 10.1016/S0195-6701(13)60012-2.
9
ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients.ESCMID 指南：管理感染控制措施以减少住院患者中多重耐药革兰氏阴性菌传播。
Clin Microbiol Infect. 2014 Jan;20 Suppl 1:1-55. doi: 10.1111/1469-0691.12427.
10
An ongoing national intervention to contain the spread of carbapenem-resistant enterobacteriaceae.一项正在进行的全国性干预措施，旨在遏制碳青霉烯类耐药肠杆菌科的传播。
Clin Infect Dis. 2014 Mar;58(5):697-703. doi: 10.1093/cid/cit795. Epub 2013 Dec 4.
Zotero 插件